3 completed. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
Follow Genelex Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacogenetic Testing Among Home Health Patients Pharmacogenetic testing - Adverse Drug Events, Adverse Drug Reactions | Not applicable | Completed | Genelex Corporation | 110 | 2015-03-01 | 2019-09-20 |
| Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM Pharmacogenetic testing, Software-based drug & gene interaction risk analysis, MTM - Cytochrome P450 CYP2D6 Enzyme Deficiency, Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Not applicable | Completed | Genelex Corporation | 341 | 2015-02-01 | 2017-02-23 |
| YouScript IMPACT Registry Adverse Drug Events, Adverse Drug Reactions | Completed | Genelex Corporation | 800 | 2014-10-01 | 2017-03-01 |
Drug Metabolism, Poor, CYP2C19-Related (3) · Drug Metabolism, Poor, CYP2D6-Related (3) · Drug-Related Side Effects and Adverse Reactions (3) · Chronic Disease (1) · Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, Type 2 (1)
United States (3)
Diana Brixner, PhD, RPh (1) · Jonathan W Magness, PharmD (1) · Lindsay Elliott, PharmD (1)